Robust antiviral activity of R1626, a no
โ
Stuart K. Roberts; Graham Cooksley; Gregory J. Dore; Richard Robson; David Shaw;
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 511 KB
The nucleoside analog R1479 is a potent and highly selective inhibitor of nonstructural protein 5B-directed hepatitis C virus (HCV) replication in vitro. R1626, a tri-isobutyl ester prodrug of R1479, was developed to increase bioavailability and improve antiviral activity. A multicenter, observer-bl